Riccardo Mayer/ShutterstockThe majority of South African HIV patients could be switched to the World Health Organization’s recommended first-line regimen if the country adopts advice from leading doctors. This would allow most people currently on the antiretroviral drug tenofovir to stay on that medication while adding dolutegravir and lamivudine to their HIV treatment regimen.
Read the full story at Aidsmap.
SEE ALSO:
- Spotlight: South Africa: Over 3 million people on new HIV drug, but not all smooth sailing
Source : Aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.